Related Business Topics
Latest Headlines
Reuters - Nov. 18, 2009, 3:55 AM
DUBLIN--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/4e2e61/ophthalmic_pharmac) has announced the addition of the 'Ophthalmic Pharmaceutical Drugs - A Global Market Perspective' report to their offering. Prevention ...
Reuters - Nov. 9, 2009, 4:26 PM
Akorn, Inc. is engaged in manufacturing and marketing diagnostic and therapeutic pharmaceuticals in specialty areas, such as ophthalmology, rheumatology, anesthesia and antidotes, among others. In addition, the Company markets and distributes vaccines ...
Reuters - Oct. 29, 2009, 5:01 PM
THOMSON REUTERS, Corporate Conference Call/Webcast for US Companies for Tuesday, Aug 11, 2009. S&P 500 Earnings - Weekly [SP500/WK] S&P 500 Earnings - Day Ahead [ESTEARN/SP] Non S&P 500 - Weekly [NSP500/WK] Non S&P 500 - Day Ahead [ESTEARN/] ...
Forbes.com - Oct. 26, 2009, 4:55 PM
LAKE FOREST, Ill. Subject: Akorn Third Quarter 2009 Conference Call Date/Time: Tuesday, November 10, 2009 The live broadcast of Akorn's conference call will also be available online at www.akorn.com About Akorn, Inc. Akorn, ...
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
A
Akorn, Inc. / Ophthalmic Division
Producer of non-injectable ophthalmic diagnostic agents and pharmaceutical products. Products are sold to multiple industries. This company was capitalized by corporate investment.
www.akorn.com
Producer of non-injectable ophthalmic diagnostic agents and pharmaceutical products. Products are sold to multiple industries. This company was capitalized by corporate investment.
www.akorn.com
